Key result
Hippocampal atrophy is linked to increased cardiac events and worse prognosis in chronic HF.
Why the study?
Screening for mild cognitive impairment using hippocampal atrophy assessment is important due to its association with increased mortality in patients with chronic heart failure.
Cohort (n=491)
Answers are grounded in this paper and cite their sources.
Mild cognitive impairment (MCI) impedes a patient's decision-making ability to support self-care and is associated with increased mortality in patients with chronic heart failure (CHF). Thus, screening for MCI is very important. The assessment of hippocampal atrophy using magnetic resonance imaging can effectively diagnose early MCI. The purpose of this study was to assess the prevalence and prognostic significance of hippocampal atrophy using magnetic resonance imaging in patient with CHF. Of the 491 patients with CHF included in the study, 170 demonstrated hippocampal atrophy. Patients with hippocampal atrophy were older, and showed a higher rate of renal dysfunction and cardiac events than patients without hippocampal atrophy. A total of 180 cardiac events occurred during the follow-up period. A Cox proportional hazards regression model and Kaplan-Meier analysis showed that hippocampal atrophy was significantly associated with cardiac events. In conclusion, hippocampal atrophy is a significant and independent predictor of poor prognosis in patients with CHF and can aid risk stratification of these patients.
No takes yet. Share an insight, caveat, or question.
Niizeki et al. (2019) conducted a cohort in Chronic Heart Failure (n=491). Hippocampal atrophy vs. No hippocampal atrophy was evaluated on Cardiac events. Hippocampal atrophy, present in 170 of 491 patients with chronic heart failure, was significantly associated with cardiac events and served as an independent predictor of poor prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: